APA (7th ed.) Citation

C, B., J, v. d. A., G, L., J, L., DM, C., ES, K., . . . GJ, G. (2021). Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects. Drugs in R&D, 21(3), 295. https://doi.org/10.1007/s40268-021-00352-5

Chicago Style (17th ed.) Citation

C, Bakker, van der Aart J, Labots G, Liptrot J, Cross DM, Klaassen ES, Dickinson S, Tasker T, and Groeneveld GJ. "Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects." Drugs in R&D 21, no. 3 (2021): 295. https://doi.org/10.1007/s40268-021-00352-5.

MLA (9th ed.) Citation

C, Bakker, et al. "Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects." Drugs in R&D, vol. 21, no. 3, 2021, p. 295, https://doi.org/10.1007/s40268-021-00352-5.